IL6 and neoplasm: Meanwhile, in the TME, tumor-associated fibroblasts and immunosuppressive cells, including myeloid-derived suppressor cells (MDSCs), regulatory T cells (Tregs), and M2-type tumor-associated macrophages (TAMs), release signaling substances such as TGF-β and IL-6 that promote drug resistance (10, 11).